Literature DB >> 30802944

Trends in cause of death among patients with multiple myeloma in Puerto Rico and the United States SEER population, 1987-2013.

Maira A Castañeda-Avila1, Karen J Ortiz-Ortiz2, Carlos R Torres-Cintrón2, Brenda M Birmann3, Mara M Epstein1,4.   

Abstract

Multiple myeloma (MM) survival has improved due to recent developments in MM treatment. As a result, other co-morbid conditions may be of increasing importance to MM patients' long-term survival. This study examines trends in common causes of death among patients with MM in Puerto Rico, and in the US Surveillance, Epidemiology, and End Results (SEER) population. We analyzed the primary cause of death among incident MM cases recorded in the Puerto Rico Central Cancer Registry (n = 3,018) and the US SEER Program (n = 67,733) between 1987 and 2013. We calculated the cumulative incidence of death due to the eight most common causes and analyzed temporal trends in mortality rates using joinpoint regression. Analyses of SEER were also stratified by Hispanic ethnicity. MM accounted for approximately 72% of all reported deaths among persons diagnosed with MM in Puerto Rico and in SEER. In both populations, the proportion of patients who died from MM decreased with increasing time since diagnosis. Age-standardized temporal trends showed a decreased MM-specific mortality rate among US SEER (annual percent change [APC] = -5.0) and Puerto Rican (APC = -1.8) patients during the study period, and particularly after 2003 in non-Hispanic SEER patients. Temporal decline in non-MM causes of death was also observed among US SEER (APC = -2.1) and Puerto Rican (APC = -0.1) populations. MM-specific mortality decreased, yet remained the predominant cause of death for individuals diagnosed with MM over a 26-year period. The most pronounced decreases in MM-specific death occurred after 2003, which suggests a possible influence of more recently developed MM therapies.
© 2019 UICC.

Entities:  

Keywords:  Puerto Rico; cause of death; multiple myeloma; temporal trends

Mesh:

Year:  2019        PMID: 30802944      PMCID: PMC6708774          DOI: 10.1002/ijc.32232

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  Permutation tests for joinpoint regression with applications to cancer rates.

Authors:  H J Kim; M P Fay; E J Feuer; D N Midthune
Journal:  Stat Med       Date:  2000-02-15       Impact factor: 2.373

2.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

Review 3.  Second malignancies after multiple myeloma: from 1960s to 2010s.

Authors:  Anish Thomas; Sham Mailankody; Neha Korde; Sigurdur Y Kristinsson; Ingemar Turesson; Ola Landgren
Journal:  Blood       Date:  2012-02-06       Impact factor: 22.113

4.  Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups.

Authors:  Sikander Ailawadhi; Ibrahim T Aldoss; Dongyun Yang; Pedram Razavi; Wendy Cozen; Taimur Sher; Asher Chanan-Khan
Journal:  Br J Haematol       Date:  2012-04-26       Impact factor: 6.998

5.  Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States.

Authors:  Luciano J Costa; Ilene K Brill; James Omel; Kelly Godby; Shaji K Kumar; Elizabeth E Brown
Journal:  Blood Adv       Date:  2017-01-04

Review 6.  International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

Authors:  S Vincent Rajkumar; Meletios A Dimopoulos; Antonio Palumbo; Joan Blade; Giampaolo Merlini; María-Victoria Mateos; Shaji Kumar; Jens Hillengass; Efstathios Kastritis; Paul Richardson; Ola Landgren; Bruno Paiva; Angela Dispenzieri; Brendan Weiss; Xavier LeLeu; Sonja Zweegman; Sagar Lonial; Laura Rosinol; Elena Zamagni; Sundar Jagannath; Orhan Sezer; Sigurdur Y Kristinsson; Jo Caers; Saad Z Usmani; Juan José Lahuerta; Hans Erik Johnsen; Meral Beksac; Michele Cavo; Hartmut Goldschmidt; Evangelos Terpos; Robert A Kyle; Kenneth C Anderson; Brian G M Durie; Jesus F San Miguel
Journal:  Lancet Oncol       Date:  2014-10-26       Impact factor: 41.316

Review 7.  Treatment of multiple myeloma.

Authors:  S Vincent Rajkumar
Journal:  Nat Rev Clin Oncol       Date:  2011-04-26       Impact factor: 66.675

8.  Cancer Statistics for Hispanics/Latinos, 2018.

Authors:  Kimberly D Miller; Ann Goding Sauer; Ana P Ortiz; Stacey A Fedewa; Paulo S Pinheiro; Guillermo Tortolero-Luna; Dinorah Martinez-Tyson; Ahmedin Jemal; Rebecca L Siegel
Journal:  CA Cancer J Clin       Date:  2018-10-04       Impact factor: 508.702

9.  Improved survival in multiple myeloma and the impact of novel therapies.

Authors:  Shaji K Kumar; S Vincent Rajkumar; Angela Dispenzieri; Martha Q Lacy; Suzanne R Hayman; Francis K Buadi; Steven R Zeldenrust; David Dingli; Stephen J Russell; John A Lust; Philip R Greipp; Robert A Kyle; Morie A Gertz
Journal:  Blood       Date:  2007-11-01       Impact factor: 22.113

10.  Infections in Hospitalised Patients with Multiple Myeloma: Main Characteristics and Risk Factors.

Authors:  Toni Valković; Vedrana Gačić; Jelena Ivandić; Božo Petrov; Renata Dobrila-Dintinjana; Elizabeta Dadić-Hero; Antica Načinović-Duletić
Journal:  Turk J Haematol       Date:  2015-09       Impact factor: 1.831

View more
  5 in total

1.  Trends of incidence, mortality and survival of multiple myeloma in Spain. A twenty-three-year population-based study.

Authors:  D-Y-L Chang-Chan; R Ríos-Tamayo; M Rodríguez Barranco; D Redondo-Sánchez; Y González; R Marcos-Gragera; M J Sánchez
Journal:  Clin Transl Oncol       Date:  2021-01-12       Impact factor: 3.405

Review 2.  Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic Strategies.

Authors:  Mattia D'Agostino; Luca Bertamini; Stefania Oliva; Mario Boccadoro; Francesca Gay
Journal:  Cancers (Basel)       Date:  2019-12-13       Impact factor: 6.639

3.  Cardiovascular-specific mortality among multiple myeloma patients: a population-based study.

Authors:  Xuejiao Yin; Fengjuan Fan; Bo Zhang; Yu Hu; Chunyan Sun
Journal:  Ther Adv Hematol       Date:  2022-03-31

4.  Causes of death in primary plasma cell leukemia differ from multiple myeloma: A STROBE-compliant descriptive study based on SEER database.

Authors:  Xiaoyan Ge; Weihan Meng; Wenbo Wang; Honglin Ma; Siqi Zhao; Kai Cui
Journal:  Medicine (Baltimore)       Date:  2022-07-22       Impact factor: 1.817

5.  Reduction in Late Mortality Among Patients With Multiple Myeloma Treated With Autologous Peripheral Blood Stem Cell Transplantation-A Blood or Marrow Transplant Survivor Study Report.

Authors:  Smith Giri; Yanjun Chen; Jessica Wu; Lindsey Hageman; Joshua Richman; Liton Francisco; Wendy Landier; Luciano Costa; Andrew McDonald; Donna Murdaugh; F Lennie Wong; Daniel J Weisdorf; Stephen J Forman; Mukta Arora; Saro H Armenian; Smita Bhatia
Journal:  Transplant Cell Ther       Date:  2021-06-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.